|
HS Code |
299609 |
| Product Name | HyaMatrix® VII+ 7-Molecular Hyaluronic Acid |
| Type | Hyaluronic Acid Serum |
| Number Of Hyaluronic Acid Molecules | 7 |
| Molecular Weights Included | Ultra-low to high molecular weight |
| Primary Function | Hydration |
| Texture | Lightweight |
| Suitable For Skin Types | All skin types |
| Application Area | Face |
| Usage Frequency | Daily |
| Main Benefit | Deep skin moisturization |
| Free From | Fragrances, parabens |
| Formulation | Water-based |
| Absorption Rate | Fast-absorbing |
| Packaging | Dropper bottle |
| Made In | South Korea |
As an accredited HyaMatrix® VII+ 7-Molecular Hyaluronic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | HyaMatrix® VII+ 7-Molecular Hyaluronic Acid comes in a sleek white 30ml bottle, labeled with blue accents and secure pump dispenser. |
| Shipping | HyaMatrix® VII+ 7-Molecular Hyaluronic Acid ships in sealed, temperature-controlled packaging to maintain product stability. Each container is securely boxed to prevent damage during transit. Shipping typically includes tracking and insurance, ensuring safe and timely delivery in compliance with regulations for cosmetic and laboratory-grade chemicals. Expedited shipping is available upon request. |
| Storage | HyaMatrix® VII+ 7-Molecular Hyaluronic Acid should be stored in a cool, dry place away from direct sunlight and heat sources. Keep the container tightly closed to protect from moisture and contamination. Recommended storage temperature is 2–25°C (36–77°F). Avoid freezing. Ensure the product is kept in its original packaging until use to maintain stability and effectiveness. |
Applications of HyaMatrix® VII+ 7-Molecular Hyaluronic Acid in Industrial ManufacturingHyaMatrix® VII+ 7-Molecular Hyaluronic Acid, developed in-house with precise molecular fractionation, supports multiple high-value industrial sectors. Below, we detail genuine application scenarios, compliance frameworks, integration methods, compositional ratios, and final product outcomes for each key downstream segment using our multi-molecular hyaluronic acid technology. 1. Advanced Cosmetic FormulationsCosmetic manufacturers use our multi-molecular hyaluronic acid for skin hydration, anti-aging serums, and dermal hydrogel formulations. By combining seven distinct molecular weights, R&D teams achieve targeted hydration profiles—from surface moisture retention to deep epidermal penetration. Formulators optimize blends for specific end-user needs, such as plumping serums or intensive overnight masks, controlling viscosity and skin absorption rate during batch production while complying with local personal care ingredient regulations. Periodic QC measures include molecular weight verification and endotoxin testing before filling and packaging. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Injectable Medical Device HydrogelsMakers of sterile medical hydrogels for viscoelastic or dermal filler applications use our multi-molecular hyaluronic acid to achieve controlled rheology and predictable tissue integration. Multi-modal molecular sizes increase cohesivity and minimize post-injection migration. Manufacturing protocols include strict environmental controls (ISO Class 7 or higher), and our material supports batch-specific traceability and endotoxin verification. Approved for non-animal derived HA CMO production, our ingredient enables rapid scale-up and stable sterilization performance by autoclave or aseptic filtration, meeting stringent medical device requirements for patient safety and polymer purity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Biomedical Drug Delivery SystemsPharmaceutical developers include our multi-molecular hyaluronic acid in hydrogel matrices designed for sustained-release drug delivery. The graduated polymer sizes generate complex mesh structures that control molecule diffusion rates, suitable for topical, transdermal, and parenteral administration vehicles. Selected for biocompatibility and proven lack of immunogenicity, the ingredient supports compliance with ICH and FDA requirements related to excipient quality, endotoxin levels, GMP documentation, and traceable supply chain. During scale-up, R&D formulators optimize HA mass fractions to match drug solubilization, release duration, and depot formation for each specific Active Pharmaceutical Ingredient (API). Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Food and Beverage Functional IngredientsProducers of functional drinks, dairy prototypes, and granulated food supplements rely on our hyaluronic acid for human nutrition and joint support claims. We supply food-grade material with multi-range molecular sizes, enabling both fast absorption and longer mucosal persistence. Producers adjust HA percentages according to recipe, pH, and regulatory limits for each market. We supply Compositional Analysis Certificates by batch including molecular size distribution and purity, supporting hassle-free regulatory documentation. Quality control includes heavy metal screening, and we maintain allergen, animal origin, and GMO-free declarations as standard toppings for all outgoing food batches. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Veterinary and Animal Health PreparationsManufacturers of oral, topical, and injectable animal health products blend our hyaluronic acid for joint, wound, and ophthalmic veterinary formulations. Controlled fractionation of molecular weights enables tailored tissue hydration and lubricity in both companion animal and livestock sectors. We follow regulations that vary per species and region, and supply compliance documentation and traceability to each batch including suitability for use in animal health as per VICH and local veterinary drug standards. Large-scale formulations are verified for microbial contamination and polymer content at every stage of downstream production before release for veterinary use. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
6. Medical Wound-Care Dressing ManufacturingSpecialist medical textile and hydrocolloid dressing fabricators utilize our hyaluronic acid in both non-woven and hydrogel components designed for moist wound environments. The presence of multiple molecular weights allows material scientists to balance water retention with controlled skin absorption, supporting granulation and re-epithelialization in chronic wounds. Manufacturing QC teams validate every lot for bioburden, residual solvents, and polymer size, complying with worldwide medical device and wound dressing directives. Process engineers integrate HA dosing either pre-polymerization or via impregnation/soaking after base dressing formation inside a controlled environment. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive HyaMatrix® VII+ 7-Molecular Hyaluronic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
From the manufacturing floor to the research bench, our journey with hyaluronic acid taught us one clear lesson: not all hyaluronic acid delivers the same results. At our plant, we've spent years monitoring the demands of skin care, cosmeceutical, and pharmaceutical formulators. Many struggled to balance deep hydration with rapid penetration and lasting film-formation. We kept asking ourselves—why put users in a position to choose between surface comfort and deep tissue effects? This recurring challenge led us to develop HyaMatrix® VII+. Our approach involved refining fermentation, purification, and fractionation steps to capture hyaluronic acid fractions at seven distinct molecular weights, each retained for a unique property, creating a synergistic effect you don't find in standard monomer or bimodal-grade options.
Traditionally, commercial hyaluronic acid comes in single or dual molecular weight options. Some manufacturers focus on a medium-weight product for ease of use, while others offer a “low” or “ultra-low” molecular grade, which comes with rapid absorption but often skips the longer-lasting, moisture-locking feel. A few combine two fractions for broader coverage. We recognized this doesn't fully reflect the performance users want, especially across different skin types and environmental conditions. HyaMatrix® VII+ brings together seven tailored fractions, ranging from ultra-low to ultra-high molecular weight. The smallest units, under 5 kDa, drive intense, targeted hydration that reaches deeper layers. Fractions closer to 800 kDa fill the intermediate zone, supporting plumpness and tactile flexibility. Larger weights, up to 2,000 kDa, create a surface mesh that resists transepidermal water loss. This cascade structure produces a sequenced absorption and moisture-release effect, rather than a single spike followed by rapid dissipation.
Our R&D team runs side-by-side testing on solubility, spreadability, and resistance to enzymatic breakdown. We have watched as single-weight products underperform in complex formulas. Product separation, unexpected gelling, or inconsistent hydration lines always come up. HyaMatrix® VII+ presents itself as a fine, almost invisible powder, dissolving quickly in both water and polar solvents without clumping or dusting. This quality helps formulators build serums, masks, injectables, and hydrogels with sharper batch-to-batch reproducibility. Since all the fractions blend seamlessly, end users see no leftovers or residue, which minimizes waste and boosts consumer confidence. Clinical feedback suggests less risk of irritation, thanks to the high purity and absence of animal-derived contaminants—a direct result of our handling at every stage, from controlled fermentation to multi-step microfiltration.
Any formulator who has faced the limits of a two-weight acid mix knows the struggle to satisfy diverse claims in a single product. A lotion calling for fast skin absorption often can't keep up with requests for a “glossy,” non-sticky finish that lingers over time. Injectables crafted for extended-release properties may seem to offer initial plumping, but falter weeks later as the low-weight fraction disappears. HyaMatrix® VII+ was crafted to serve both purposes without drastic reformulation. Using the full seven-weight spectrum, users have found stronger film-forming strength for surface hydration, while deep penetration characteristics back up real skin rejuvenation claims. We have measured reduced water loss over a 12-hour window, compared to single- or dual-weight HA at similar concentrations. In lab-scale production runs, our team observed faster incorporation and much lower risk of gel phase separation under shear forces.
Feedback from cosmeceutical labs and clinical dermatologists keeps guiding our process. Their input runs from texture and mixability in prototype creams to the stability of actives in medical-grade fillers. Each molecular weight in HyaMatrix® VII+ provides a distinct site of action: the smallest fragments enhance intercellular communication and quick plumping, intermediate sizes anchor these effects, and the larger polymers generate protective films that don’t wash away easily, even under stress. This structural design means finished goods developed with our product routinely receive higher ratings on hydration, smoothness, and appearance, across diverse climatic zones and skin types. We keep hearing how this multifaceted protection anticipates the varied lifestyles and routines of today’s users in ways standard hyaluronate products simply cannot.
Consistency forms the backbone of pharmaceutical-grade hyaluronate sourcing. Our site integrates automated bioreactor monitoring to ensure each fermentation cycle stays well within critical parameters. Purification skips the use of animal byproducts or harsh organic solvents, which addresses rising concern over allergens and environmental safety. The powder that leaves our facility shows undetectable endotoxin and protein counts—an achievement confirmed routinely through third-party validation. We refine the seven fractions through a cascade of ultrafiltration membranes, measuring average molecular mass through GPC and light scattering before each blend. This hands-on, metrics-driven process minimizes batch variability. Formulators who tested HyaMatrix® VII+ across several lots report reliable rehydration times and no unexpected shifts in skin feel, a frequent worry with materials sourced through multiple intermediaries or poorly managed supply chains.
Cleansers, serums, and sheet masks present wildly different compatibility requirements. Many low-weight hyaluronates destabilize acid-sensitive actives, while larger fractions can compete with niacinamide, peptides, or vitamin C for surface Dearrangement. Testing our seven-fraction approach revealed improved compatibility even with notoriously finicky ingredients. Vitamin C serums made with HyaMatrix® VII+ resist texture shifts and minimize crystallization, opening doors for more ambitious formulation. End users with allergy histories or hypersensitivity issues report lower redness and fewer breakouts, a direct result of minimal impurity signatures. Repeated use by testers prone to surface dryness produced fewer flaking incidents. All this feeds back to our labs, prompting tighter controls and further tweaks to the blends, never compromising on performance.
Bringing this product out of pilot scale proved an exercise in listening—really listening—to both our internal teams and our most demanding partners. We scaled batches in response to short shelf-life criticism, fine-tuned drying temperatures to avoid denaturation, and invested in aseptic packaging to meet medical usage requirements. Our ability to provide consistent shipments month after month doesn't just come from having more steel in the ground—it reflects years adjusting protocols and offering transparent QC records. Feedback from large-scale contract manufacturers pointed out the edge given by our powder’s fast dispersion, especially for automated or continuous production setups. Our direct involvement in loading, blending, and shipping means no step is left unchecked, reducing transit damage and limiting downtime.
During the early years making HA, we saw first-hand how excessive solvent washing and inconsistent microbial control can introduce real risks to customers and the environment. Our site eliminated the use of animal-sourced materials, switching to non-GMO microbial fermentation. Purification wastes are contained, and discharge is treated above regulatory standards, exceeding local requirements for effluent safety. This isn’t just a box-ticking measure—it responds directly to the real-world concerns voiced by both clients and end-users worried about cross-contamination, residual antibiotics, and hazardous byproducts. Endotoxin clearance receives double-layer monitoring, with every outgoing lot tested for microbial contaminants and adverse pyrogenic effects. Facilities built for full GMP operation underpin our value pledge: users can trust what reaches their plants or clinics because every line item on our certificates is cross-checked by experienced, on-site staff.
In cosmetology and dermatology practice, product failure becomes immediately obvious. Injectable HA that migrates, topical gels that pill, or serums that clog pores all undermine brand trust. We designed HyaMatrix® VII+ not just to fulfill a higher list of technical requirements but also to meet the wider range of clinical outcomes trusted practitioners look for: predictable hydration without rebound dryness, real dermal improvement for sensitive cases, and long-term barrier protection even with repeated use. Clinics running side-by-side trials saw visually measurable differences between single-weight and multi-weight HA solutions, including less visible irritation and more robust post-procedural support. Dermatologists wanting more flexibility to address mixed skin types finally have a non-surgical option that shields while it heals.
Open communication with partners fuels every development cycle. Customers care about substance integrity, transparency in claims, and real people seeing improvements they can notice. We have faced calls to expand packaging options for smaller-scale labs, to provide granular traceability for regulatory purposes, and to supply micro-lot samples for experimental purposes without compromising mainline production. Every priority, from anti-pollution barrier validation to advanced 3D tissue model compatibility, started with a single request from partners who trust our openness to feedback.
Over time, we realized the true value behind this multi-fraction approach shines brightest in real life. Sheet masks layered with our product stay moist longer, support stronger cutaneous comfort, and produce a more even toning—a stark contrast to thinner, fast-evaporating alternatives. Athletes and outdoor workers, frequently exposed to wind and sun, reported less tightness and burning after applying formulations built on our seven-weight structure. For busy clinics, our powder’s quick dissolve time speeds up preparation without the risks of filament formation, which saves both staff time and end-user skin comfort. Across personal care products and innovative clinical devices, the evidence keeps pointing in one direction: combining multiple fractions provides more durable, layered hydration and reduced side effects.
At the end of each production round, we take a moment to revisit the driving force behind this innovation—the shared experience of working side by side with clinicians, formulators, and users. HyaMatrix® VII+ reflects the best synthesis of long-term learning, tried-and-tested process control, and dedication to customer needs. By closely managing every part of the chain, from fermentation to blending and shipping, we create a seven-fraction hyaluronic acid built for modern products. It enables skincare and medicine creators to move beyond compromise formulas and finally deliver nuanced, targeted benefits that actually last. This journey taught us genuine progress comes from listening, adapting, and keeping quality at the heart of every decision. For us, that’s where the next generation of hyaluronic acid begins.
